A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
Public ClinicalTrials.gov record NCT01170078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study Comparing the Pharmacokinetics of Epoetin Hospira and Epoetin Alfa (Amgen) When Administered Intravenously in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
Study identification
- NCT ID
- NCT01170078
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Hospira, now a wholly owned subsidiary of Pfizer
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- Epoetin Hospira Drug
- Epogen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Dec 31, 2010
- Completion
- Dec 31, 2010
- Last update posted
- Mar 19, 2017
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Downey | California | 90241 | — |
| Not listed | Tarzana | California | 91356-6123 | — |
| Not listed | Denver | Colorado | 80230 | — |
| Not listed | Middlebury | Connecticut | 06762 | — |
| Not listed | Lauderdale Lakes | Florida | 33313 | — |
| Not listed | Miami | Florida | 33150 | — |
| Not listed | Miami | Florida | 33173 | — |
| Not listed | Gurnee | Illinois | 60031 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | Pontiac | Michigan | 48341 | — |
| Not listed | Minneapolis | Minnesota | 55404 | — |
| Not listed | Gulfport | Mississippi | 39501 | — |
| Not listed | Philadelphia | Pennsylvania | 19106 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Knoxville | Tennessee | 37923 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Houston | Texas | 77099 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Alexandria | Virginia | 22306 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01170078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01170078 live on ClinicalTrials.gov.